Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant inhibitor of human plasma kallikrein

EU orphan designation number: EU/3/02/126
Active ingredient: Recombinant inhibitor of human plasma kallikrein
Indication: treatment of angioedema
Sponsor: Dyax s.a.
159B Oudemoeder, B-4880 Aubel, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/12/2002 Orphan designation EMEA/OD/043/02 (2002)5443 of 18/12/2002
28/04/2009 Change of name and/or address of sponsor
17/06/2014 Removal of orphan designation from Community Register